Matrix analysis of gene expression in cells (magec)
    1.
    发明申请
    Matrix analysis of gene expression in cells (magec) 审中-公开
    细胞中基因表达的基质分析(magec)

    公开(公告)号:US20060088834A1

    公开(公告)日:2006-04-27

    申请号:US10510722

    申请日:2003-04-14

    IPC分类号: C12Q1/68 C12N15/87

    摘要: The invention provides a novel expression cloning technique referred to as a matrix analysis of gene expression in cells (MAGEC) that allows for the indexed introduction, and analysis of nucleic acids in a host cell. While normally one takes cells attached to a surface followed by contacting the cells with heterologous DNA under conditions favoring the uptake of the heterologous DNA, the present invention, in sharp contrasts, proposes affixing (depositing) a nucleic acid-containing mixture onto a suitable surface and thereafter contacting suitable host cells (target cells) with the DNA-containing markings under conditions favoring uptake by the cells of the heterologous expression vector comprising a the target nucleic slide acid molecule. The method enables one to further characterize the gene product(s) of a known gene and unknown in a high-throughput assay format. It essentially allows for the identification of a gene based upon the function of its gene product.

    摘要翻译: 本发明提供了一种新颖的表达克隆技术,被称为能够进行索引引入的细胞中的基因表达(MAGEC)的基因分析和宿主细胞中核酸的分析。 尽管通常,在有利于异源DNA摄取的条件下,通常将细胞附着于表面,随后将细胞与异源DNA接触,本发明的鲜明对照提出将含核酸的混合物附着(沉积)到合适的表面上 然后在有利于细胞摄取包含靶核酸载体酸分子的异源表达载体的条件下,使合适的宿主细胞(靶细胞)与含有DNA的标记接触。 该方法使得能够进一步表征已知基因的基因产物,并且以高通量测定形式未知。 它基本上允许基于其基因产物的功能鉴定基因。

    METHODS FOR THE SELECTIVE MODULATION OF PPAR
    2.
    发明申请
    METHODS FOR THE SELECTIVE MODULATION OF PPAR 审中-公开
    PPAR选择性调节方法

    公开(公告)号:US20070190079A1

    公开(公告)日:2007-08-16

    申请号:US11687949

    申请日:2007-03-19

    IPC分类号: A61K31/495

    CPC分类号: A61K31/495

    摘要: The present invention relates to methods of selective modulation of peroxisome proliferator activated receptors (PPARs) over G-protein coupled receptor 40 (GPR40), and the use of therapeutically effective amounts of compounds and pharmaceutical compositions which selectively modulate PPAR over GPR40 for the treatment of diseases in patients in need thereof. The methods disclosed herein are exceptionally useful in treating metabolic diseases whilst avoiding certain side effects common to modulators of PPAR previously disclosed in the art.

    摘要翻译: 本发明涉及在G蛋白偶联受体40(GPR40)上选择性调节过氧化物酶体增殖物激活受体(PPAR)的方法,以及使用治疗有效量的化合物和药物组合物,其选择性调节PPR在GPR40上的治疗 有需要的患者的疾病。 本文公开的方法在治疗代谢疾病方面特别有用,同时避免了本领域先前公开的PPAR调节剂的常见副作用。